Cell Signaling Technology

Product Pathways - Neuroscience

Phospho-Tau (Thr181) Antibody #5383

Applications Reactivity Sensitivity MW (kDa) Source
W IP H M R (Mk) Endogenous 50-80 Rabbit

Applications Key:  W=Western Blotting  IP=Immunoprecipitation
Reactivity Key:  H=Human  M=Mouse  R=Rat  Mk=Monkey
Species cross-reactivity is determined by western blot. Species enclosed in parentheses are predicted to react based on 100% sequence homology.

Protocols

Specificity / Sensitivity

Phospho-Tau (Thr181) Antibody recognizes endogenous levels of Tau protein only when phosphorylated at Thr181.

Source / Purification

Polyclonal antibodies are produced by immunizing animals with a synthetic phosphopeptide corresponding to residues surrounding Thr181 of human Tau protein. Antibodies are purified by protein A and peptide affinity chromatography.

Western Blotting

Western Blotting

Western blot analysis of extracts from mouse and rat brain using Tau (Tau46) Mouse mAb #4019 (red) and Phospho-Tau (Thr181) Antibody (green). The phospho-specificity of Phospho-Tau (Thr181) Antibody was verified by peptide blocking using a phosphopeptide or non-phosphopeptide. Western blot image was obtained using the Odyssey® Infrared Imaging System (LI-COR® Biotechnology).

Western Blotting

Western Blotting

Western blot analysis of extracts from mouse and rat brain using Phospho-Tau (Thr181) Antibody.

Background

Tau is a heterogeneous microtubule-associated protein that promotes and stabilizes microtubule assembly, especially in axons. Six isoforms with different amino-terminal inserts and different numbers of tandem repeats near the carboxy terminus have been identified, and tau is hyperphosphorylated at approximately 25 sites by Erk, GSK-3, and CDK5 (1,2). Phosphorylation decreases the ability of tau to bind to microtubules. Neurofibrillary tangles are a major hallmark of Alzheimer's disease; these tangles are bundles of paired helical filaments composed of hyperphosphorylated tau. In particular, phosphorylation at Ser396 by GSK-3 or CDK5 destabilizes microtubules. Furthermore, research studies have shown that inclusions of tau are found in a number of other neurodegenerative diseases, collectively known as tauopathies (1,3).

The cerebrospinal fluid concentration of Tau phosphorylated at Thr181 has been proposed to be a biomarker for the study of neurodegenerative disorders (4).

  1. Johnson , G.V. and Stoothoff , W.H. (2004) J. Cell Sci. 117, 5721-5729.
  2. Hanger, D. P. et al. (1998) J. Neurochem. 71, 2465-2476.
  3. Bramblett, G. T. et al. (1993) Neuron 10, 1089-1099.
  4. Mitchell, A.J. (2009) J Neurol Neurosurg Psychiatry 80, 966-75.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products


For Research Use Only. Not For Use In Diagnostic Procedures.

Products